Literature DB >> 18471878

Spinal glial activation contributes to pathological pain states.

Hong Cao1, Yu-Qiu Zhang.   

Abstract

Chronic pain, a pathological state, affects millions of people worldwide. Despite decades of study on the neuronal processing of pain, mechanisms underlying the creation and maintenance of enhanced pain states after injury or inflammation remain far from clear. In the last decade, however, the discovery that glial activation amplifies pain has challenged classic neuronal views of "pain". This review focuses on recent developments in understanding that spinal cord glia are involved in pathological pain. We overview the action of spinal glia (both microglia and astrocytes) in several persistent pain models, and provide new evidence that spinal glia activation contributes to the development and maintenance of arthritic pain facilitation. We also attempt to discuss some critical questions, such as how signals are conveyed from primary afferents to spinal glia following peripheral nerve injury and inflammation. What causes glia to become activated after peripheral/central injury/inflammation? And how the activated glia alter neuronal sensitivity and pain processing? Answers to these questions might open a new approach for treatment of pathological pain.

Entities:  

Mesh:

Year:  2008        PMID: 18471878     DOI: 10.1016/j.neubiorev.2008.03.009

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  84 in total

Review 1.  The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs.

Authors:  Haroon Hameed; Mariam Hameed; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-04

2.  Role of microglia and astrocyte in central pain syndrome following electrolytic lesion at the spinothalamic tract in rats.

Authors:  Kobra Naseri; Elham Saghaei; Fatemeh Abbaszadeh; Mina Afhami; Ali Haeri; Farzaneh Rahimi; Masoumeh Jorjani
Journal:  J Mol Neurosci       Date:  2012-06-22       Impact factor: 3.444

Review 3.  The pain of tendinopathy: physiological or pathophysiological?

Authors:  Ebonie Rio; Lorimer Moseley; Craig Purdam; Tom Samiric; Dawson Kidgell; Alan J Pearce; Shapour Jaberzadeh; Jill Cook
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

4.  Transient changes in spinal cord glial cells following transection of preganglionic sympathetic axons.

Authors:  Aminata P Coulibaly; Lori G Isaacson
Journal:  Auton Neurosci       Date:  2012-01-29       Impact factor: 3.145

Review 5.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.

Authors:  Linda R Watkins; Mark R Hutchinson; Kenner C Rice; Steven F Maier
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

6.  Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury.

Authors:  Angelo C Lepore; John O'Donnell; Andrew S Kim; Eun Ju Yang; Alisha Tuteja; Amanda Haidet-Phillips; Colin P O'Banion; Nicholas J Maragakis
Journal:  Glia       Date:  2011-08-31       Impact factor: 7.452

7.  Distribution of purinergic P2X receptors in the equine digit, cervical spinal cord and dorsal root ganglia.

Authors:  D E Zamboulis; J M Senior; P D Clegg; J A Gallagher; S D Carter; P I Milner
Journal:  Purinergic Signal       Date:  2013-02-06       Impact factor: 3.765

8.  CX3CR1 Mediates Nicotine Withdrawal-Induced Hyperalgesia via Microglial P38 MAPK Signaling.

Authors:  Yonghong Ding; Wenhui Shi; Guannan Xie; Ailan Yu; Qinghe Wang; Zongwang Zhang
Journal:  Neurochem Res       Date:  2015-09-19       Impact factor: 3.996

Review 9.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

10.  A peptide antagonist of the TLR4-MD2 interaction.

Authors:  Peter F Slivka; Mitesh Shridhar; Gui-in Lee; Deanne W Sammond; Mark R Hutchinson; Alexander J Martinko; Madison M Buchanan; Page W Sholar; Jeffrey J Kearney; Jacqueline A Harrison; Linda R Watkins; Hang Yin
Journal:  Chembiochem       Date:  2009-03-02       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.